- Home
- CBFV vs ANTX Comparison
CBFV vs ANTX Comparison
Compare CBFV & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | ANTX |
|---|---|---|
| Founded | 1901 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 172.9M |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CBFV | ANTX |
|---|---|---|
| Price | $37.87 | $4.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $38.00 | $2.00 |
| AVG Volume (30 Days) | 2.5K | ★ 189.9K |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ 32.56 |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $43,557,000.00 | N/A |
| Revenue This Year | $48.93 | N/A |
| Revenue Next Year | $7.97 | N/A |
| P/E Ratio | $23.95 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.97 | $1.00 |
| 52 Week High | $38.86 | $7.19 |
Technical Indicators
Market Signals| Indicator | CBFV | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 33.25 |
| Support Level | $36.88 | $4.55 |
| Resistance Level | $37.78 | $5.21 |
| Average True Range (ATR) | 0.43 | 0.36 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 38.46 | 5.33 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.